EdgarLookup

Acrivon Therapeutics, Inc. — S-3 Filings

2 S-3 filings on record

This page lists all S-3 filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 2 S-3 documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 424B4 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-1MEF S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
S-3 S-3 0001193125-24-099152 Apr 17, 2024 —
S-3 S-3 0001193125-23-287501 Dec 1, 2023 —